171-180 of 299 results

Diagnostic methods remain patentable in Australia
Insight 14 Jul 2019

The Federal Court has confirmed diagnostic methods remain patent-eligible subject matter in Australia. The Court's highly anticipated decision in the Sequenom case provides a strong impetus for innovators to continue to develop new diagnostic methods in the important field of biotechnology. ...

Unity of porpoise means no mere aqua-escence in latest Trident decision
Insight 11 Aug 2019

The latest appeal decision in a longstanding trade mark feud between US-based seafood giant Trident Seafoods Corporation and Australian company Trident Foods Pty Ltd has eased the burden of establishing authorised use of a trade mark by companies within the same corporate group ...

Use of your own name must be in good faith
Insight 12 Aug 2019

Even where a family business is making use of its own surname, trade mark infringement and passing off are likely to be found where the conduct is not in good faith and has caused actual confusion. ...

IP insurance: are you sure it's too expensive?
Insight 25 Jun 2019

IP disputes can be costly. One way firms can manage this risk is to obtain IP insurance. Once regarded as too expensive to work, recent developments in the market suggest that, for smaller businesses in particular, protection may now be more affordable. ...

A grape result – exporter of copycat Penfolds wines ordered to pay
Insight 25 Jun 2019

Companies exporting wine labelled with the Chinese equivalent of Australia's famous Penfolds brand have been ordered to pay more than $350,000 in damages for trade mark infringement. ...

Global trade mark update
Insight 25 Jun 2019

There have been significant, and proposed, trade mark law developments across the globe which are likely to inform trade mark portfolio strategy. ...

Licence to infringe: Patent Office grants Sandoz licence to exploit Lexapro® patent
Insight 25 Jun 2019

In the latest chapter of one the longest-running sagas in Australian patent litigation history, the Deputy Commissioner of Patents has retrospectively granted Sandoz a licence to exploit Lundbeck's patent for its blockbuster antidepressant Lexapro® (escitalopram). The licence, only the second of its kind to be granted in Australia, provides Sandoz with a defence to Lundbeck's multi-million dollar infringement claim. ...

Stylkea – a bad idea?
Insight 25 Jun 2019

This Insight considers two recent examples of Australian businesses clashing with multinational businesses in relation to trade marks which serve as cautionary tales for all businesses. ...

I like it [trade marked] like that, OKURRR?
Insight 18 Apr 2019

American rapper Cardi B brought trade mark law into news headlines recently when the rapper's company, Washpoppin Inc., lodged trade mark applications in the US for 'OKURRR ...

An overhaul of regulation of software as a medical device - what's on the horizon?
Insight 22 Mar 2019

Proposed new regulatory rules for software as a medical device will if enacted have serious implications for suppliers to the Australian market who will likely have to meet more stringent requirements that could conflict with those in the US and Europe Special Counsel Ric Morgan and Senior Associate ...

Refine